{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'hospitalization (for a severe exacerbation). Prior use of antibiotics alone does not', 'qualify as an exacerbation history unless the use was associated with treatment of', 'worsening symptoms of COPD, such as increased dyspnea, sputum volume, or', 'sputum purulence (color). Subject verbal reports are not acceptable.', 'Refer to the SPM for details on what is accepted as documented history of AECOPD.', 'Refer to Table 2 for the definitions of moderate and severe AECOPD.', 'Current or former tobacco smoker (cigarette) with a smoking history of > 10 pack-', 'years OR a subject exposed to biomass smoke for > 20 years [Guoping Hu, 2010]', 'Refer to the glossary of terms for the definitions of pack-years, current and former', 'smoker.', 'Able to provide a sputum sample at Screening Visit.', '4.3.', 'Exclusion criteria for enrolment (Amended 19 October 2018)', 'Deviations from exclusion criteria are not allowed because they can potentially jeopardise', 'the scientific integrity and regulatory acceptability of the study or subject safety.', 'Therefore, adherence to the criteria as specified in the protocol is essential.', 'The following criteria should be checked at the time of study entry. If ANY exclusion', 'criterion applies, the subject must not be included in the study:', 'Diagnosed with a respiratory disorder other than COPD (such as sarcoidosis, active', 'tuberculosis or receiving tuberculosis treatment, clinically significant bronchiectasis,', 'lung fibrosis, pulmonary embolism, pneumothorax, lung cancer diagnosed within the', 'previous 5 years, current primary diagnosis of asthma in the opinion of the', 'investigator), or chest X-ray revealing evidence of clinically significant', 'abnormalities not believed to be due to the presence of COPD* Subjects with', 'allergic rhinitis do not need to be excluded and may be enrolled at the discretion of', 'the investigator.', '* A chest X-ray must be taken at Screening Visit, if no chest X-ray taken within the', 'previous 3 months is available.', 'Diagnosis of a-1 antitrypsin deficiency as the underlying cause of COPD.', 'Undergone or has had lung surgery 12 months before, or plans to have lung surgery', '12 months after, study entry.', 'Any confirmed or suspected immunosuppressive or immunodeficient condition,', 'based on medical history and physical examination (no laboratory testing required).', 'Received chemotherapy within the 12 months before study entry.', 'Concurrently participating in another clinical study, at any time during the study', 'period, in which the subject has been or will be exposed to an investigational or a', 'non-investigational vaccine/product (pharmaceutical product or device).', '19-OCT-2018', '38', '5661ebdab2e949f7a1f1bc2071b9dec72aceccf']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'Administration of antibiotics within 1 month of study entry OR continuous', 'administration of antibiotics (defined as more than 30 days in total) within 90 days', 'before study entry*', '*Study entry is Visit 1. If this exclusion criteria is met during Screening Visit the', 'patient can enter the study and this exclusion criteria will be reassessed during', 'Visit 1.', 'Systemic administration of corticosteroids (PO/IV/IM) for more than 14 consecutive', 'days within 90 days prior to informed consent.', 'Contraindication for spirometry testing (such as recent eye surgery, recent thoracic or', 'abdominal surgery procedures, unstable cardiovascular status, recent myocardial', 'infarction or pulmonary embolism).', 'Psychiatric illness or any other condition that interferes with the ability to understand', 'the study procedures.', 'Pregnant female.', '19-OCT-2018', '39', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']\n\n###\n\n", "completion": "END"}